Discover what the measure aims to change, who it affects, and why it matters.
For full details and official documents, visit the Commission’s site
Reception Date
02.10.19
Category
PHARMACEUTICAL AND COSMETICS
Pharmaceuticals
Ministries & Departments
Ministerstvo zdravotnictví České republiky, odbor legislativní
Responsible Departments
Úřad pro technickou normalizaci, metrologii a státní zkušebnictví
Products & Services concerned
Medicinal products for human use according to the definition under Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
Related EU Law
-
The previous amendment supplemented the Act with measures against undesirable distribution outside the Czech market of medicinal products intended for Czech patients.
The purpose of the draft Act is to contribute to better availability of pharmaceuticals to Czech patients through a combination of interrelated measures:
This timeline summarizes key events in the notification process
Track the evolution of this law — uncover the changes made from draft to final version based on input from the Commission, key organisations, and Member States.
This might mean the notification is still being reviewed,
or the final legislation hasn’t been uploaded to the system.
Organisation | Comments | Date | Total Contributions |
---|---|---|---|
EAEPC - European Association of Euro-Pharmaceutical Companies | Not published | 2019-11-28 | 2 |